• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Waldencast plc - Class A Ordinary Share (NQ:WALD)

    1.760 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 534
    Open 1.760
    Bid (Size) 1.660 (1,800)
    Ask (Size) 1.790 (400)
    Prev. Close 1.760
    Today's Range 1.760 - 1.760
    52wk Range 0.7200 - 3.220
    Shares Outstanding 9,342,874
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
    Approval Further Expands Obagi Medical’s Injectable Portfolio and Strengthens Its Position as a Leading Dermatological Megabrand 
    From Waldencast plc
    Via GlobeNewswire
    Which stocks are experiencing notable movement on Monday? ↗
    Via Chartmill

    Performance

    YTD
    +2.9%
    +2.9%
    1 Month
    -3.8%
    -3.8%
    3 Month
    +85.3%
    +85.3%
    6 Month
    -10.2%
    -10.2%
    1 Year
    -28.2%
    -28.2%

    More News

    Read More
    News headline image
    Waldencast Announces Sale of Obagi Medical to Bridgepoint
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience
    From Waldencast plc
    Via GlobeNewswire
    Unusual volume stocks are being observed in Thursday's session. ↗
    Via Chartmill
    News headline image
    Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*
    From Waldencast plc
    Via GlobeNewswire
    Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    Waldencast announces conclusion of SEC investigation
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Waldencast Reports Q4 2025 and FY 2025 Financial Results
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi Medical and It’s a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    CORRECTION – Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
    From Waldencast plc
    Via GlobeNewswire
    News headline image
    Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
    From Waldencast plc
    Via GlobeNewswire

    Frequently Asked Questions

    Is Waldencast plc - Class A Ordinary Share publicly traded?
    Yes, Waldencast plc - Class A Ordinary Share is publicly traded.
    What exchange does Waldencast plc - Class A Ordinary Share trade on?
    Waldencast plc - Class A Ordinary Share trades on the Nasdaq Stock Market
    What is the ticker symbol for Waldencast plc - Class A Ordinary Share?
    The ticker symbol for Waldencast plc - Class A Ordinary Share is WALD on the Nasdaq Stock Market
    What is the current price of Waldencast plc - Class A Ordinary Share?
    The current price of Waldencast plc - Class A Ordinary Share is 1.760
    When was Waldencast plc - Class A Ordinary Share last traded?
    The last trade of Waldencast plc - Class A Ordinary Share was at 06/30/26 04:00 PM ET
    What is the market capitalization of Waldencast plc - Class A Ordinary Share?
    The market capitalization of Waldencast plc - Class A Ordinary Share is 16.44M
    How many shares of Waldencast plc - Class A Ordinary Share are outstanding?
    Waldencast plc - Class A Ordinary Share has 16M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.